What is CJC-1295 (No DAC) + Ipamorelin Blend?
This blend combines CJC-1295 NO DAC (a growth hormone-releasing hormone analog without drug affinity complex) and Ipamorelin (a selective GH-releasing peptide) to synergistically stimulate endogenous growth hormone (GH) release.
-
CJC-1295 NO DAC stimulates GH release via pituitary somatotroph activation without extending half-life excessively.
-
Ipamorelin binds the ghrelin receptor (GHS-R1a), triggering pulsatile GH release with minimal impact on appetite or cortisol.
The combination is used in research to study enhanced GH release, improved recovery, and metabolic effects while minimizing side effects from single agents.
Research Applications
- Growth hormone axis and secretagogue studies
- Muscle hypertrophy and protein synthesis research
- Fat metabolism and lipolysis investigations
- Tissue regeneration and recovery studies
- Endocrine signaling and GH pulse pattern analysis
- Comparative studies with GHRP-2, GHRP-6, and other GH-releasing compounds
- Anti-aging and metabolic regulation research
Quick Product Specs
- Form: Lyophilized Powder
- CAS Number: Not publicly standardized (peptide combination)
- Molecular Formula: Sequence-specific (CJC-1295 NO DAC + Ipamorelin)
- Storage: -20°C (long-term) / 2–8°C after reconstitution
- Shelf Life: 24 months unopened
- Type: Synthetic Peptide Blend / Growth Hormone Secretagogues
-
Composition (per vial)
CJC-1295 (No DAC) – 5 mg
Ipamorelin – 5 mg
Certificate of Analysis (COA)
https://verify.janoshik.com/tests/93613-Ipamorelin_CJC1295_NO_DAC_blend_10mg_each_HVP9R3LJ1PAV





